Chargement en cours...
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
The prognosis of children with metastatic neuroblastoma (NB) > 18 months at diagnosis is dismal. Since the immune status of the tumor microenvironment could play a role in the history of disease, we evaluated the expression of CD45, CD14, ARG1, CD163, CD4, FOXP3, Perforin-1 (PRF1), Granzyme B (GR...
Enregistré dans:
| Publié dans: | Biomed Res Int |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486282/ https://ncbi.nlm.nih.gov/pubmed/26161395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/347867 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|